Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for SOLENO THERAPEUTICS INC COMMON STOCK (SLNO).
- Disclosed ownership: 6.9%.
- Date of event: 30 Jun 2025.
PRICE T ROWE ASSOCIATES INC /MD/ - 30 Jun 2025 SCHEDULE 13G/A Report for SOLENO THERAPEUTICS INC COMMON STOCK (SLNO)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Security
- SOLENO THERAPEUTICS INC COMMON STOCK
- Symbol
- SLNO
- Shares outstanding
- 50,166,812 shares
- Disclosed Ownership
- 3,461,510 shares
- Ownership
- 6.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 13:07:20 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 14 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 6.9% ownership in SOLENO THERAPEUTICS INC COMMON STOCK (SLNO) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 14 May 2025.
- Current filing was accepted on 14 Aug 2025, 13:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 6.9% | 3,461,510 | 3,421,107 | 0 | Ellen York | Vice President |